- Home
- PACB
as 07-08-2024 4:00pm EST
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | MENLO PARK |
| Market Cap: | 479.3M | IPO Year: | 2010 |
| Target Price: | $6.59 | AVG Volume (30 days): | 7.6M |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.14 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.16 - $14.55 | Next Earning Date: | 07-31-2024 |
| Revenue: | $200,431,000 | Revenue Growth: | 49.54% |
| Revenue Growth (this year): | -8.27% | Revenue Growth (next year): | 33.10% |
Stock Insider Trading Activity of Pacific Biosciences of California Inc. (PACB)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Farmer Michele | PACB | See Remarks | May 20 '24 | Sell | $2.03 | 5,275 | $10,708.25 | 211,941 | SEC Form 4 |
| Meline David W | PACB | Director | Mar 6 '24 | Buy | $4.40 | 40,000 | $176,160.00 | 40,000 | SEC Form 4 |
| Farmer Michele | PACB | See Remarks | Mar 4 '24 | Sell | $4.87 | 2,968 | $14,457.13 | 217,216 | SEC Form 4 |
| Van Oene Mark | PACB | See Remarks | Mar 4 '24 | Sell | $4.87 | 9,186 | $44,745.01 | 1,668,826 | SEC Form 4 |
| Kim Susan G. | PACB | See Remarks | Mar 4 '24 | Sell | $4.87 | 5,275 | $25,694.53 | 712,260 | SEC Form 4 |
| HENRY CHRISTIAN O | PACB | See Remarks | Mar 4 '24 | Sell | $4.87 | 14,177 | $69,056.17 | 2,596,670 | SEC Form 4 |
| Eidel Jeff | PACB | See Remarks | Feb 16 '24 | Sell | $5.96 | 15,498 | $92,337.08 | 431,824 | SEC Form 4 |
| Farmer Michele | PACB | See Remarks | Feb 16 '24 | Sell | $5.96 | 7,562 | $45,054.40 | 101,164 | SEC Form 4 |
| Van Oene Mark | PACB | See Remarks | Feb 16 '24 | Sell | $5.96 | 33,560 | $199,950.48 | 876,611 | SEC Form 4 |
| HENRY CHRISTIAN O | PACB | See Remarks | Feb 16 '24 | Sell | $5.96 | 79,038 | $470,908.40 | 1,007,057 | SEC Form 4 |
| HENRY CHRISTIAN O | PACB | See Remarks | Feb 16 '24 | Sell | $5.26 | 1,979 | $10,411.52 | 1,005,078 | SEC Form 4 |
| Kim Susan G. | PACB | See Remarks | Feb 16 '24 | Sell | $5.96 | 22,496 | $134,031.17 | 283,589 | SEC Form 4 |
| Kim Susan G. | PACB | See Remarks | Feb 16 '24 | Sell | $5.26 | 831 | $4,371.89 | 282,758 | SEC Form 4 |
| Van Oene Mark | PACB | See Remarks | Jan 9 '24 | Sell | $7.77 | 31,012 | $241,056.28 | 910,171 | SEC Form 4 |
| HENRY CHRISTIAN O | PACB | See Remarks | Dec 14 '23 | Sell | $10.00 | 20,000 | $200,000.00 | 1,086,095 | SEC Form 4 |
Latest Pacific Biosciences of California Inc. News
PACB Breaking Stock News: Dive into PACB Ticker-Specific Updates for Smart Investing
Zacks
6 days ago
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
Zacks
7 days ago
PacBio (PACB) and Form Bio to Boost AAV Industry Development
Zacks
10 days ago
Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors
Insider Monkey
11 days ago
Pacific Biosciences of California, Inc (PACB): A Good Buy According to Analysts?
ACCESSWIRE
11 days ago
Form Bio and PacBio Announce Collaboration to Launch New Resources Set to Transform AAV Design and Analysis Best Practices
Zacks
20 days ago
Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know
PR Newswire
a month ago
PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database
CNW Group
a month ago
Media Advisory - Prime Minister's itinerary for Sunday, June 9, 2024
Share on Social Networks:
Disclaimer
The information presented on this page, "PACB Pacific Biosciences of California Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.